References
1
Sonnenschein H.
Kosslick H.
Tittelbach F.
Synthesis
1998,
1596
2
Kreher T.
Sonnenschein H.
Costisella B.
Schneider M.
J. Chem. Soc., Perkin Trans. 1
1997,
3451
3
Blake AJ.
Dick JW.
Leaver D.
Strachan P.
J. Chem. Soc., Perkin Trans. 1
1991,
2991
4
Poissonnet G.
Theret-Bettiol M.-H.
Dodd RH.
J. Org. Chem.
1996,
61:
2273
5
Harrell WB.
Doerge RF.
J. Pharm. Sci.
1967,
56:
225
6 Wheeler JW. inventors; Eur. Pat. Appl. EP 161789.
; Chem. Abstr. 1985, 104, 170108
7
Weidner CH.
Wadsworth DH.
Bonder SL.
Beltman DJ.
J. Org. Chem.
1989,
54:
3660
8a
Gubin J.
Lucchetti J.
Nisato D.
Rosseels G.
Clinet M.
Polster P.
J. Med. Chem.
1992,
35:
981
8b
Nugent RA.
Murphy M.
J. Org. Chem.
1987,
52:
2206
9
Chai W.
Kwok A.
Wong V.
Carruthers NI.
Wu J.
Synlett
2003,
2086
10a
Katritzky AR.
Qiu G.
Yang B.
He HY.
J. Org. Chem.
1999,
64:
7618
10b
Zhang XC.
Huang WY.
J. Fluorine Chem.
1998,
92:
13
10c
Zhu SZ.
Qin C.
Wang Y.
Chu Q.
J. Fluorine Chem.
1999,
99:
183
10d
Zhang X.
Cao W.
Wei X.
Hu H.
Synth. Commun.
1997,
27:
1395
10e
Wang B.
Zhang X.
Li J.
Hu Y.
Hu H.
J. Chem. Soc., Perkin Trans. 1
1999,
1571
10f
Druta II.
Andrei MA.
Aburel PS.
Tetrahedron
1998,
54:
2107
10g
Druta II.
Dinica RM.
Bacu E.
Humelnicu I.
Tetrahedron
1998,
54:
10811
11
Zhou J.
Hu Y.
Hu H.
Synthesis
1999,
166
12a
Basavaiah D.
Rao AJ.
Chem. Commun.
2003,
604
12b
Chai W.
Breitenbucher JG.
Kwok A.
Li X.
Wong V.
Carruthers NI.
Lovenberg TW.
Mazur C.
Wilson SJ.
Axe FU.
Jones TK.
Bioorg. Med. Chem. Lett.
2003,
13:
1767
13a
Matsumato K.
Hayashi N.
Ikemi Y.
Toda M.
Uchida T.
Aoyama K.
Miyakoshi Y.
J. Heterocycl. Chem.
2001,
38:
371
13b
Peng W.
Zhu S.
J. Chem. Soc., Perkin Trans. 1
2001,
3204
13c
Boultadakis E.
Chung B.
Elsegood MRJ.
Weaver GW.
Synlett
2002,
1547
13d
Shen Y.
Zhang Y.
Jiang G.
Synthesis
2002,
714
13e
Chen WK.
Qing Y.
Synthesis
2003,
35
14
Bora U.
Saikia A.
Boruah RC.
Org. Lett.
2003,
5:
435
15
Goff DA.
Tetrahedron Lett.
1999,
40:
8741
16a
Chen Z.
Yang G.
Zhang Z.
Wang D.
Synthesis
2001,
1483
16b
Yang G.
Chen Z.
Zhang Z.
Qiu X.
Synth. Commun.
2002,
32:
3637
16c
Chen Z.
Yang G.
Zhang Z.
Synth. Commun.
2003,
33:
729
16d
Yang G.
Chen Z.
Zhang G.
Chin. J. Chem.
2002,
20:
178
16e
Hu C.
Chen Z.
Yang G.
Chin. J. Chem.
2003,
10:
1494
17
Preparation of PEG-Supported Pyridinium Salt 2
To a solution of PEG3400 (8 g, 4.71 mmol OH) and DIPEA (1.6 mL, 9.42 mmol) in dry CH2Cl2 (50 mL) was added dropwise a solution of bromoacetyl bromide (0.8 mL, 9.42 mmol) in dry CH2Cl2 (2 mL) at 0 °C and stirred at r.t. overnight. The mixture was washed with H2O to remove NH4Br, dried over MgSO4 and concentrated. After precipitation with cold Et2O, washing with cold Et2O and drying under vacuum, a white solid 1 was obtained. Into a solution of 1 in dry CH2Cl2 (20 mL) was added pyridine (1.52 mL, 9.42 mmol) and stirred at r.t. for 18 h. After precipitation from cold Et2O, the suspension was filtered and washed with cold Et2O to give solid 2 (8.8 g, 98%). TLC (EtOAc-petroleum ether, 1:4) showed that the solid was free from any low molecular reactants and by-products.
IR (KBr): 2883, 1750, 1114 cm-1. 1H NMR (600 MHz, CDCl3): δ = 9.42 (d, 2 H, J = 6.6 Hz, α-pyridine), 8.68 (t, 1 H, J = 8.7 Hz, γ-pyridine), 8.19 (t, 2 H, J = 7.2 Hz, β-pyridine), 6.16 (s, 2 H, -CH2COO-), 3.77-3.52 [m, 4n H, -O(CH2CH2O)n-].
18
Typical Procedure for Preparation of Indolizines 5
A solution of 2 (2 g, 0.53 mmol), 3 (2.12 mmoL), TPCD (0.65 g, 1.06 mmoL) and DIPEA (0.18 mL, 1.06 mmol) in DMF (30 mL) was stirred at 80-90 °C for 3-4 h. After the solvent was evaporated under vacuum, the residue was added CH2Cl2 (50 mL) and filtered. The filtrate was washed with H2O to remove NH4Br, dried over MgSO4, filtered, concentrated and precipitated with cold Et2O to give 4. Product 4 was treated with a 1% solution of KCN in MeOH (30 mL) and stirred at r.t. overnight, evaporated MeOH and precipitated with cold Et2O to give the crude products, which were purified by column chromatography on silica gel (EtOAc-petroleum ether, 1:4) to afford the pure 5.
5a: IR (KBr): 1678, 1635 cm-1. 1H NMR (600 MHz, CDCl3): δ = 9.65 (d, 1 H, J = 7.2 Hz, C-5), 8.08 (d, 1 H, J = 9.0 Hz, C-8), 7.46-7.03 (m, 12 H, C-6, C-7, Ph), 3.62 (s, 3 H,
-COOMe). Anal. Calcd for C23H17NO3: C, 77.73; H, 4.82; N, 3.94. Found: C, 77.68; H, 4.80; N, 3.97.
5b: IR (KBr): 1684, 1633 cm-1. 1H NMR (600 MHz, CDCl3): δ = 9.64 (d, 1 H, J = 6.6 Hz, C-5), 8.04 (d, 1 H, J = 9.0 Hz, C-8), 7.47-6.88 (m, 11 H, C-6, C-7, Ph), 3.66 (s, 3 H, -COOMe), 2.22 (s, 3 H, Me). Anal. Calcd for C24H19NO3: C, 78.03; H, 5.18; N, 3.79. Found: C, 78.00; H, 5.14; N, 3.82.
5c: IR (KBr): 1686, 1627 cm-1. 1H NMR (600 MHz, CDCl3): δ = 9.64 (d, 1 H, J = 4.2 Hz, C-5), 8.08 (d, 1 H, J = 7.8 Hz, C-8), 7.46-6.61 (m, 11 H, C-6, C-7, Ph), 3.71 (s, 3 H,
-COOMe), 3.67 (s, 3 H, -OMe). Anal. Calcd for C24H19NO4: C, 74.79; H, 4.97; N, 3.63. Found: C, 74.81; H, 4.94; N, 3.67.
5d: IR (KBr): 1687, 1634 cm-1. 1H NMR (600 MHz, CDCl3): δ = 9.67 (d, 1 H, J = 6.6 Hz, C-5), 8.11 (d, 1 H, J = 9.0 Hz, C-8), 7.47-6.79 (m, 11 H, C-6, C-7, Ph), 3.67 (s, 3 H, -COOMe). Anal. Calcd for C23H16NFO3: C, 73.99; H, 4.32; N, 3.75. Found: C, 73.96; H, 4.38; N, 3.79.
5e: IR (KBr): 1681, 1627 cm-1. 1H NMR (600 MHz, CDCl3): δ = 9.65 (d, 1 H, J = 7.2 Hz, C-5), 8.05 (d, 1 H, J = 9.0 Hz, C-8), 7.45-7.03 (m, 11 H, C-6, C-7, Ph), 3.65 (s, 3 H,
-COOMe). Anal. Calcd for C23H16NClO3: C, 70.86; H, 4.14; N, 3.59. Found: C, 70.90; H, 4.14; N, 3.62.
5f: IR (KBr): 1686, 1634 cm-1. 1H NMR (600 MHz, CDCl3): δ = 9.65 (d, 1 H, J = 7.2 Hz, C-5), 8.05 (d, 1 H, J = 9.0 Hz, C-8), 7.45-7.03 (m, 11 H, C-6, C-7, Ph), 3.65 (s, 3 H,
-COOMe). Anal. Calcd for C23H16NBrO3: C, 63.61; H, 3.71; N, 3.23. Found: C, 63.57; H, 3.74; N, 3,24.
5g: IR (KBr): 1686, 1629, 1531 cm-1. 1H NMR (600 MHz, CDCl3): δ = 9.66 (d, 1 H, J = 7.8 Hz, C-5), 8.00 (d, 1 H, J = 9.6 Hz, C-8), 7.47-7.09 (m, 11 H, C-6, C-7, Ph), 3.63 (s, 3 H, -COOMe). Anal. Calcd for C23H16N2O5: C, 69.00; H, 4.03; N, 7.00. Found: C, 68.71; H, 4.00; N, 6.75.
5h: IR (KBr): 1686, 1625, 1533 cm-1. 1H NMR (600 MHz, CDCl3): δ = 9.67 (d, 1 H, J = 6.6 Hz, C-5), 8.06 (d, 1 H, J = 7.2 Hz, C-8), 7.44-7.13 (m, 11 H, C-6, C-7, Ph), 3.63 (s, 3 H, -COOMe). Anal. Calcd for C23H16N2O5: C, 69.00; H, 4.03; N, 7.00. Found: C, 68.66; H, 4.05; N, 6.73.
5i: IR (KBr): 1682, 1628,1535 cm-1. 1H NMR (600 MHz, CDCl3): δ = 9.66 (d, 1 H, J = 7.2 Hz, C-5), 8.04 (d, 1 H, J = 8.4 Hz, C-8), 7.47-7.08 (m, 11 H, C-6, C-7, Ph), 3.63 (s, 3 H, -COOMe). Anal. Calcd for C23H16N2O5: C, 69.00; H, 4.03; N, 7.00. Found: C, 68.64; H, 4.02; N, 6.71.
5j: IR (KBr): 2226, 1682, 1628 cm-1. 1H NMR (600 MHz, CDCl3): δ = 9.66 (d, 1 H, J = 6.6 Hz, C-5), 8.03 (d, 1 H, J = 9.0 Hz, C-8), 7.45-7.09 (m, 11 H, C-6, C-7, Ph), 3.63 (s, 3 H, -COOMe). Anal. Calcd for C24H16N2O3: C, 75.78; H, 4.24; N, 7.36. Found: C, 75.74; H, 4.22; N, 7.38.
5k: IR (KBr): 1687, 1634 cm-1. 1H NMR (600 MHz, CDCl3): δ = 9.61 (d, 1 H, J = 6.0 Hz, C-5), 8.15 (d, 1 H, J = 8.4 Hz, C-8), 7.56-6.13 (m, 10 H, C-6, C-7, Ph, -furan), 3.82 (s, 3 H, -COOMe). Anal. Calcd for C21H15NO4: C, 73.04; H, 4.38; N, 4.06. Found: C, 73.06; H, 4.34; N, 4.09.
5l: IR (KBr): 1688, 1647 cm-1. 1H NMR (600 MHz, CDCl3): δ = 9.59 (d, 1 H, J = 7.2 Hz, C-5), 8.65 (d, 1 H, J = 9.0 Hz, C-8), 7.62-6.49 (m, 5 H, C-6, C-7, -furan), 3.74 (s, 3 H,
-COOMe), 2.02 (s, 3 H, -Me). Anal. Calcd for C16H13NO4: C, 67.84; H, 4.63; N, 4.94. Found: C, 67.88; H, 4.60; N, 4.87.
5m: IR (KBr): 1676, 1637 cm-1. 1H NMR (600 MHz, CDCl3): δ = 9.60 (d, 1 H, J = 6.6 Hz, C-5), 8.66 (d, 1 H, J = 9.0 Hz, C-8), 7.76-7.03 (m, 7 H, C-6, C-7, Ph, -furan), 3.52 (s, 3 H, -COOMe), 1.82 (s, 3 H, -Me). Anal. Calcd for C18H15NO3: C, 73.71; H, 5.15; N, 4.78. Found: C, 73.76; H, 5.11; N, 4.82.
5n and 8b: IR (KBr): 1702, 1637 cm-1. 1H NMR (600 MHz, CDCl3): δ = 9.56 (d, 1 H, J = 7.2 Hz, C-5), 8.37 (d, 1 H, J = 7.8 Hz, C-8), 8.02 (s, 1 H, C-2), 7.36 (t, 1 H, J = 7.8 Hz, C-7), 7.03 (t, 1 H, J = 6.6 Hz, C-6), 3.95 (s, 3 H, -COOMe), 3.94 (s, 3 H, -COOMe). Anal. Calcd for C12H11NO4: C, 61.80; H, 4.75; N, 6.01. Found: C, 61.77; H, 4.71; N, 6.00.
19
Typical Procedure for Preparation of Indolizines 8
A solution of 2 (2 g, 0.53 mmol), 6 (2.12 mmoL) and DIPEA (0.18 mL, 1.06 mmol) in toluene was stirred at 90 °C for 2 h. After solvent was removed, the residue was dissolved in CH2Cl2 (50 mL) washed, dried, filtered, concentrated, precipitated and cleaved by using the procedure described above for 5. The crude product was purified by column chromatography on silica gel (EtOAc-petroleum ether, 1:2) to afford pure 8.
8a: IR (KBr): 1736, 1715, 1697 cm-1. 1H NMR (600 MHz, CDCl3): δ = 9.53 (d, 1 H, J = 6.6 Hz, C-5), 8.35 (d, 1 H, J = 9.0 Hz, C-8), 7.40 (t, 1 H, J = 7.8 Hz, C-7), 7.07 (t, 1 H, J = 7.2 Hz, C-6), 4.03 (s, 3 H, -COOMe), 3.92 (s, 3 H,
-COOMe), 3.92 (s, 3 H, -COOMe). Anal. Calcd for C14H13NO6: C, 57.73; H, 4.50; N, 4.81. Found: C, 57.77; H, 4.51; N, 4.85.